16-02-2009 Comments (0)
ActosAvastinAventis PharmabevacizumabDaiichi SankyoEffientHumulin 70-30Humulin NHumulin RInsulinLillyNystatinOralOseltamivir PhosphatePioglitazoneprasugrelPrografProtopicSankyoSanofi-AventistacrolimusTamiflu
Tokyo extended its gain for a second week, following mixed moves in the review week to February 9. The…
A trial subscription will give you access to the latest news on The Pharma Letter for 7 days, in order to evaluate the paid service.